Peer-influenced content. Sources you trust. No registration required. This is HCN.
Eyewire+
The FDA classified the nationwide recall of more than 2.5 million bottles of Lupin’s prednisolone acetate ophthalmic suspension as a Class II recall after reports of a foreign substance in affected products.
Ophthalmology July 15th 2026
Cleveland Clinic Journal of Medicine (CCJM)
Early adjunctive corticosteroids in PJP management can be lifesaving for HIV-positive patients with hypoxemia, but their efficacy in HIV-negative patients warrants further investigation.
Infectious Diseases April 29th 2024
This “From the Editor” in the Cleveland Clinic Journal of Medicine offers a nuanced view of corticosteroid therapy, highlighting the balance between their significant therapeutic benefits and the risk of adverse effects in long-term use.
Endocrinology, Diabetes, Metabolism April 15th 2024